Divi's Laboratories Beheer

Beheer criteriumcontroles 3/4

De CEO Divi's Laboratories is Kiran Divi, benoemd in Jan2020, heeft een ambtstermijn van 4.83 jaar. De totale jaarlijkse vergoeding van { bedraagt ₹ 227.50M, bestaande uit 4% salaris en 96% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 20.34% van de aandelen van het bedrijf, ter waarde ₹ 311.40B. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 4.1 jaar en 7.3 jaar.

Belangrijke informatie

Kiran Divi

Algemeen directeur

₹227.5m

Totale compensatie

Percentage CEO-salaris	4.0%
Dienstverband CEO	4.8yrs
Eigendom CEO	20.3%
Management gemiddelde ambtstermijn	4.1yrs
Gemiddelde ambtstermijn bestuur	7.3yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Kiran Divi's beloning veranderd ten opzichte van Divi's Laboratories's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	₹18b
Jun 30 2024	n/a	n/a	₹17b
Mar 31 2024	₹228m	₹9m	₹16b
Dec 31 2023	n/a	n/a	₹14b
Sep 30 2023	n/a	n/a	₹13b
Jun 30 2023	n/a	n/a	₹15b
Mar 31 2023	₹248m	₹9m	₹18b
Dec 31 2022	n/a	n/a	₹24b
Sep 30 2022	n/a	n/a	₹30b
Jun 30 2022	n/a	n/a	₹31b
Mar 31 2022	₹377m	₹5m	₹30b
Dec 31 2021	n/a	n/a	₹26b
Sep 30 2021	n/a	n/a	₹21b
Jun 30 2021	n/a	n/a	₹20b
Mar 31 2021	₹282m	₹10m	₹20b
Dec 31 2020	n/a	n/a	₹19b
Sep 30 2020	n/a	n/a	₹18b
Jun 30 2020	n/a	n/a	₹16b
Mar 31 2020	₹184m	₹8m	₹14b
Dec 31 2019	n/a	n/a	₹13b
Sep 30 2019	n/a	n/a	₹13b
Jun 30 2019	n/a	n/a	₹14b
Mar 31 2019	₹202m	₹8m	₹14b
Mar 31 2018	₹140m	₹8m	₹9b

Compensatie versus markt: De totale vergoeding ($USD 2.70M ) Kiran } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 1.10M ).

Compensatie versus inkomsten: De vergoeding van Kiran is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Kiran Divi (48 yo)

4.8yrs

Tenure

₹227,500,000

Compensatie

Dr. Kiran Satchandra Divi has been the Chief Executive Officer of Divi's Laboratories Limited since January 4, 2020. Dr. Divi has been an Whole-time Director at Divi's Laboratories Limited and its and ser...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Kiran Divi	CEO & Whole-Time Director	4.8yrs	₹227.50m	20.34% ₹ 311.4b
Venkata Nimmagadda	Executive Director	no data	₹331.30m	geen gegevens
Murali Krishna Divi	MD & Executive Director	no data	₹640.60m	2.88% ₹ 44.1b
Devendra Sureddy	Whole-Time Director (Manufacturing)	less than a year	₹22.58m	0.023% ₹ 346.0m
Nilima Divi	Whole-time Director	3.4yrs	₹227.40m	geen gegevens
L. Babu	Chief Financial Officer	no data	₹32.20m	geen gegevens
L. Babu	VP of Procurement & Chief Information Officer	no data	₹21.50m	geen gegevens
M. Choudhury	Company Secretary & Compliance Officer	5.3yrs	₹3.80m	geen gegevens
Satya Divi	Vice President of Sales	no data	₹28.70m	geen gegevens
Y. T. Prasad	Global Quality Head	no data	₹14.00m	0.018% ₹ 282.1m
M. Babu	Chief Technologist - PDSC	no data	₹23.60m	0.0053% ₹ 81.9m
P. Rao	Chief Technologist - PDSC	no data	₹23.60m	0.014% ₹ 216.0m

4.1yrs

Gemiddelde duur

59yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 532488 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.1 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Kiran Divi	CEO & Whole-Time Director	23.3yrs	₹227.50m	20.34% ₹ 311.4b
Venkata Nimmagadda	Executive Director	no data	₹331.30m	geen gegevens
Murali Krishna Divi	MD & Executive Director	34.1yrs	₹640.60m	2.88% ₹ 44.1b
Devendra Sureddy	Whole-Time Director (Manufacturing)	less than a year	₹22.58m	0.023% ₹ 346.0m
Nilima Divi	Whole-time Director	7.4yrs	₹227.40m	geen gegevens
Rameshbabu Nimmagadda	Independent Non-Executive Chairman	7.4yrs	₹3.30m	geen gegevens
Seru Ganapathy	Non-Executive Independent Director	7.3yrs	₹2.80m	geen gegevens
Sunaina Singh	Non-Executive Independent Director	5.7yrs	₹2.80m	geen gegevens
Kosaraju Chowdary	Non-Executive Independent Director	4.8yrs	₹3.30m	geen gegevens
Rajendra Premchand	Independent Additional Director	less than a year	geen gegevens	geen gegevens

7.3yrs

Gemiddelde duur

66yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 532488 wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.3 jaar).

Divi's Laboratories Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Chief Technologist - PDSC recently sold ₹9.8m worth of stock

Insider recently sold ₹59m worth of stock

Divi's Laboratories Limited Announces Board and Committee Changes

Insider recently sold ₹46m worth of stock

Insider recently sold ₹238m worth of stock

Divi's Laboratories Limited Approves Appointment of Dr. S. Devendra Rao as Whole-Time Director (Manufacturing)

Recent updates

Price target increased by 7.8% to ₹4,988

Second quarter 2025 earnings released: EPS: ₹19.20 (vs ₹13.11 in 2Q 2024)

Divi's Laboratories Limited to Report Q2, 2025 Results on Nov 09, 2024

Chief Technologist - PDSC recently sold ₹9.8m worth of stock

Insider recently sold ₹59m worth of stock

Divi's Laboratories Limited Declares Dividend for the Financial Year Ended March 31, 2024

Price target increased by 10% to ₹4,332

Upcoming dividend of ₹30.00 per share

Divi's Laboratories Limited to Report Q1, 2025 Results on Aug 03, 2024

Full year 2024 earnings: EPS and revenues exceed analyst expectations

Divi's Laboratories Limited Announces Board and Committee Changes

Insider recently sold ₹46m worth of stock

Insider recently sold ₹238m worth of stock

Dividend of ₹30.00 announced

Price target increased by 11% to ₹3,806

Divi's Laboratories Limited Recommends A Final Dividend for the Financial Year 2023-24

Divi's Laboratories Limited to Report Q4, 2024 Results on May 25, 2024

Divi's Laboratories Limited Approves Appointment of Dr. S. Devendra Rao as Whole-Time Director (Manufacturing)

Insider recently sold ₹24m worth of stock

Chief Technologist recently sold ₹56m worth of stock

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Divi's Laboratories Limited to Report Q3, 2024 Results on Feb 10, 2024

Insider recently sold ₹59m worth of stock

Non-Executive Independent Director recently sold ₹1.4m worth of stock

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Divi's Laboratories Limited to Report Q2, 2024 Results on Nov 06, 2023

Insider recently sold ₹3.3m worth of stock

Chief Technologist recently sold ₹2.9m worth of stock

Divi's Laboratories Limited Declares Dividend for the Financial Year Ended March 31, 2023

Divi's Laboratories Limited Informs Resignations of Directors

Price target increased by 7.3% to ₹3,325

New minor risk - Profit margin trend

Insufficient new directors

Divi's Laboratories Limited to Report Q1, 2024 Results on Aug 14, 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

New minor risk - Insider selling

Divi's Laboratories Limited, Annual General Meeting, Aug 28, 2023

Insider recently sold ₹3.4m worth of stock

Divi's Laboratories Limited Recommends a Dividend for the Financial Year 2022-23

Full year 2023 earnings released: EPS: ₹68.69 (vs ₹112 in FY 2022)

Divi's Laboratories Limited to Report Q4, 2023 Results on May 20, 2023

Insider recently sold ₹2.0m worth of stock

Global Quality Head recently sold ₹2.3m worth of stock

Global Quality Head recently sold ₹2.8m worth of stock

Global Quality Head recently sold ₹28m worth of stock

Price target decreased by 14% to ₹3,064

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Divi's Laboratories Limited to Report Q3, 2023 Results on Feb 03, 2023

MD & Executive Director recently sold ₹1.0m worth of stock

Insider recently sold ₹1.7m worth of stock

Insider recently sold ₹1.2m worth of stock

Price target decreased to ₹3,582

Price target decreased to ₹3,650

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Insider recently sold ₹1.5m worth of stock

Insider recently sold ₹3.7m worth of stock

Upcoming dividend of ₹30.00 per share

Divi's Laboratories Limited to Report Q1, 2023 Results on Aug 12, 2022

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Divi's Laboratories Limited Recommends Dividend

Divi's Laboratories Limited, Annual General Meeting, Aug 22, 2022

Insider recently sold ₹2.5m worth of stock

Insider recently sold ₹7.3m worth of stock

Divi's Laboratories Limited Recommends A Dividend for the Year 2021-2022

Price target decreased to ₹4,466

Divi's Laboratories Limited to Report Q4, 2022 Results on May 23, 2022

Insider recently sold ₹2.7m worth of stock

Board Member recently sold ₹21m worth of stock

Insider recently bought ₹796k worth of stock